GlassScriptPhysician profile
Michael P Grossman
NPI 1467455816
$3,593.81
in general payments reported to CMS, 2019-2025
16 companies · $305 in 2025
The $305 reported for 2025 was more than what 77% of Reproductive Endocrinology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $690 · 2020: $290 · 2021: $481 · 2022: $784 · 2023: $697 · 2024: $348 · 2025: $305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,349.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $1,354.03 | 2021-2025 | Pregnyl, Ganirelix Acetate, Follistim Aq |
| Emd Serono, INC. | $482.71 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $479.16 | 2019-2021 | |
| Abbvie INC. | $415.20 | 2019-2023 | |
| Ferring Pharmaceuticals INC. | $339.93 | 2019-2025 | Menopur |
| Coopersurgical, INC. | $146.04 | 2020-2023 | Stripper |
| Myovant Sciences INC. | $71.98 | 2021-2022 | |
| Novo Nordisk INC | $69.56 | 2022-2023 | Wegovy |
| Sumitomo Pharma America, INC. | $66.67 | 2023 | Myfembree |
| Cook Medical LLC | $47.33 | 2022-2023 | Guardia |
| Galen US INC | $44.38 | 2019 | |
| Lilly USA, LLC | $19.39 | 2024 | Zepbound |
| Kowa Pharmaceuticals America, INC. | $19.24 | 2022 | |
| Vertical Pharmaceuticals, LLC | $14.93 | 2019 | |
| Avion Pharmaceuticals | $13.13 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Meditrina | $10.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Grossman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.